Masimo held a 23.1% share of the US pulse oximetry systems market in 2025, as per GlobalData analysis.

Quick Read Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped ...

By Sabrina Valle and Gnaneshwar Rajan Feb 17 (Reuters) - Danaher, a $150 billion U.S. company that makes tools used in ...

Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics ...

Masimo Corporation agreed to be acquired by Danaher for $180/share, valuing MASI at $9.9B. Click here to read my most recent analysis covering the acquisition.

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...

Masimo iSpO2 pulse oximeter and the iSpO2 app. Manufactured and submitted by Masimo Corp. (Irvine, CA). The iSpO2 is a measure-through-motion and low-perfusion pulse oximeter made for iPhone and iPad.